Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement-Reference-Cited by-同舟云学术

Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement

Published:2012-06-28 Issue:8 Volume:53 Page:1185-1192
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Salaun Pierre-Yves,Campion Loïc,Bournaud Claire,Faivre-Chauvet Alain,Vuillez Jean-Philippe,Taieb David,Ansquer Catherine,Rousseau Caroline,Borson-Chazot Françoise,Bardet Stéphane,Oudoux Aurore,Cariou Bertrand,Mirallié Eric,Chang Chien-Hsing,Sharkey Robert M.,Goldenberg David M.,Chatal Jean-François,Barbet Jacques,Kraeber-Bodéré Françoise

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference36 articles.

1. Prognosis of medullary thyroid carcinoma

2. Medullary thyroid carcinoma

3. Prognostic Impact of Serum Calcitonin and Carcinoembryonic Antigen Doubling-Times in Patients with Medullary Thyroid Carcinoma

4. Phase II Study of Safety and Efficacy of Motesanib in Patients With Progressive or Symptomatic, Advanced or Metastatic Medullary Thyroid Cancer

5. Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Advances and Perspectives in Targeted Radionuclide Therapy;Pharmaceutics;2023-06-14

2. Implant Imaging: Perspectives of Nuclear Imaging in Implant, Biomaterial, and Stem Cell Research;Bioengineering;2023-04-25

3. Radiotheranostics in oncology: Making precision medicine possible;CA: A Cancer Journal for Clinicians;2023-01-09

4. Pretargeted Radiopharmaceutical Therapy;Radiopharmaceutical Therapy;2023

5. Integrated Diagnostics and Theragnostics of Medullary Thyroid Carcinoma and Related Syndromes;Integrated Diagnostics and Theranostics of Thyroid Diseases;2023